ENANTA PHARMACEUTICALS INC
ENTA · Pharmaceutical Preparations
Latest available SEC filing: SCHEDULE 13G/A ·
Latest disclosures
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Rottinghaus Scott T.: Form 4
Insider disclosure · Filed · Report period 08 Aug 2026
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ENTA · 29251M106 - Common Stock
Company details and SEC sources
CIK 0001177648 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ENTA on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 4 Kingsbury Avenue, Watertown, MA, 02472
- Fiscal year end
- 30 September
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields